Rongfu Wang Selected Research

Rongfu Wang Research Topics

Disease

28	Neoplasms (Cancer) 01/2023 - 07/2002
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 12/2018
4	Lung Neoplasms (Lung Cancer) 10/2022 - 01/2018
4	Lymphoma (Lymphomas) 01/2022 - 01/2018
3	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2022
3	Testicular Neoplasms (Testicular Cancer) 01/2022 - 12/2018
3	Malaria 11/2020 - 01/2014
3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2016
3	Cognitive Dysfunction 01/2019 - 01/2016
3	Infections 10/2018 - 01/2014
2	Glioma (Gliomas) 01/2023 - 01/2023
2	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2021
2	Disease Progression 01/2022 - 10/2020
2	Carcinoma (Carcinomatosis) 12/2021 - 01/2018
2	Adenocarcinoma of Lung 11/2020 - 12/2018
2	Virus Diseases (Viral Diseases) 11/2020 - 01/2014
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2020 - 01/2013
2	Multiple Myeloma 06/2020 - 01/2018
2	Liver Neoplasms (Liver Cancer) 01/2018 - 02/2013
2	Hepatocellular Carcinoma (Hepatoma) 02/2013 - 09/2005
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023
1	Lymphatic Metastasis 01/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Progeria (Hutchinson Gilford Syndrome) 11/2021
1	Brain Injuries (Brain Injury) 10/2021
1	Ischemia 10/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2021
1	Necrosis 11/2020
1	Thrombosis (Thrombus) 10/2020
1	Anemia 12/2018
1	Fever (Fevers) 12/2018

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2005
6	AntigensIBA 01/2023 - 07/2002
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2015
4	Monoclonal AntibodiesIBA 01/2023 - 01/2018
4	Immunoglobulin G (IgG)IBA 01/2023 - 01/2018
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023 - 10/2020
4	Peptides (Polypeptides)IBA 04/2022 - 01/2019
4	LigandsIBA 04/2022 - 01/2014
4	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2014
3	daratumumabIBA 01/2022 - 01/2018
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 12/2018
3	Arginine (L-Arginine)FDA Link 10/2021 - 02/2017
3	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2014
3	MicroRNAs (MicroRNA)IBA 02/2016 - 02/2013
2	Small Interfering RNA (siRNA)IBA 01/2023 - 02/2017
2	Messenger RNA (mRNA)IBA 11/2021 - 11/2014
2	Leucine (L-Leucine)FDA Link 10/2021 - 01/2019
2	Apolipoproteins E (ApoE)IBA 01/2019 - 01/2019
2	Amyloid (Amyloid Fibrils)IBA 01/2019 - 01/2016
1	Radioisotopes (Radionuclides)IBA 01/2023
1	Cytosine DeaminaseIBA 01/2023
1	Zinc Finger E-box-Binding Homeobox 1IBA 01/2023
1	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2022
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 04/2022
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	VaccinesIBA 01/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2021
1	Sirtuin 1IBA 11/2021
1	VER 155008IBA 10/2021
1	arginyl-arginyl-leucineIBA 10/2021
1	Biotin (Vitamin H)FDA Link 10/2021
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 10/2021
1	3-methylquercetinIBA 10/2021
1	obinutuzumabIBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	EnzymesIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 11/2020
1	squamous cell carcinoma-related antigenIBA 11/2020
1	pro-gastrin-releasing peptide (31-98)IBA 11/2020
1	CarbohydratesIBA 11/2020
1	Phosphotransferases (Kinase)IBA 11/2020
1	Tumor Biomarkers (Tumor Markers)IBA 11/2020
1	Gastrin-Releasing PeptideIBA 11/2020
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 11/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2020
1	Integrin alpha4beta1 (VLA-4)IBA 06/2020
1	CytokinesIBA 06/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	ApolipoproteinsIBA 01/2019
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2019
1	florbetapirIBA 01/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2018
1	InterferonsIBA 10/2018

Therapy/Procedure

12	Therapeutics 01/2023 - 01/2016
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2021
3	Immunotherapy 01/2022 - 07/2002
2	Radioimmunotherapy 01/2023 - 01/2021
2	Precision Medicine 01/2021 - 01/2018
1	Rejuvenation 11/2021
1	Radiotherapy 01/2021
1	Nephrectomy 10/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2018